<DOC>
	<DOCNO>NCT02599740</DOCNO>
	<brief_summary>This study design test bioequivalence assume key active compound vs. natural fruit extract judge Incremental area curve ( +iAUC0-2h ) blood glucose : i.e . 90 % confidence interval ratio +iAUC0-2h blood glucose assume key active compound vs. natural extract fall 0.8 - 1.25 .</brief_summary>
	<brief_title>Natural Fruit Extract Versus Assumed Key Active Compound Reducing Post-prandial Blood Glucose Level</brief_title>
	<detailed_description>The basic study design Williams design consist six distinct treatment sequence ; within treatment sequence treatment duplicate .</detailed_description>
	<criteria>Body mass index ( BMI ) ≥ 18.5 ≤ 25.0 kg/m2 . Apparently healthy male female : medical condition might affect study measurement , absorption , metabolism distribution ( include diabetes type 1 type 2 , gastrointestinal dysfunction , gastrointestinal surgery [ exception cholecystectomy appendectomy ] inflammatory disease ) . Fasting blood glucose value subject ≥ 3.4 &lt; 6.1 mmol/litre ( i.e . 62 110 mg/dl ) screening . Use antibiotic within 3 month day 1 ; use medication within 14 day day 1 except paracetamol hormonal contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Blood glucose</keyword>
</DOC>